Searched for
RESHORING DRUG MANUFACTURING
200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Trump administration reaches a trade deal to lower Taiwan's tariff barriersTaiwan tariff deal: The agreement comes as the U.S. remains reliant on Taiwan for its production of computer chips, the exporting of which ...
Trump eyes fresh tariff probe focused on foreign drug pricesPresident Trump is initiating a new investigation into drug prices, aiming to compel foreign nations to pay the same as Americans for their...
Trump administration targets deals in dozens of industries before midtermsThe Trump administration is aggressively pursuing deals across 20-30 critical industries, offering incentives like equity stakes and regula...
Trump mulls tariffs on foreign electronics based on number of chips: SourcesThe Trump administration is considering new tariffs on foreign electronic devices, based on their chip content, to compel manufacturing shi...
Will drug prices soar under Trump’s tariff plan?Trump’s proposed 200% tariffs on imported drugs risk pushing up U.S. prescription costs, squeezing generics, and deepening supply chain con...
200% tariffs in offing? Trump vows to slash drug prices using import restrictionsPharma Tariffs: US President Donald Trump plans to impose a 200 percent tariff on imported medicines to push drug companies into cutting pr...
China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...
US moves ahead on tariffs with investigations into computer chips, pharmaceuticalsThe Trump administration is advancing tariff plans by investigating imports of computer chips, chip-making equipment, and pharmaceuticals u...
April 2 Liberation Day and the impossible trinity at the heart of US tariffsUS President Trump's trade strategy aims to raise tax revenue, revive U.S. manufacturing, and achieve foreign policy goals. However, econom...
Eli Lilly announces $27-billion US expansion: To add 13,000 jobs and new manufacturing sitesEli Lilly & Co has announced a $27-billion expansion of its US manufacturing operations, adding four new sites and creating 13,000 jobs. Th...
T.I.D.E. Global Megatrends: How investors can navigate the next decadeTechnological disruption has consistently reshaped investment themes by transforming industries, creating new markets, and displacing estab...
Global supply chain shift: Has India finally arrived?Global supply lines are shifting for more resilience. Geopolitical developments put India at an advantage. Will demographic dividend finall...
Virus sends Narendra Modi from ‘vocal for local’ to relying on global aidNations including the U.S., the U.K., France and Germany have pledged aid after a second wave of the pandemic overwhelmed India’s healthcar...
India can attract $120-160 billion FDI annually by 2025: CII-EY reportAs per the report, India has observed a GDP growth of 6.8% in the current decade, with FDI to GDP at around 1.8%. Adopting an approach of r...